| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |